ロード中...
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
BACKGROUND: According to the Response Assessment in Neuro-Oncology criteria, new enhancement within the radiation field on contrast enhanced T1-weighted images within 12 weeks after completion of radiotherapy should not qualify for progressive disease, since up to 50% of these cases may be pseudopro...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483046/ https://ncbi.nlm.nih.gov/pubmed/25038253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou129 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|